Rare tumors, major challenges: The RACOON-SAGA project explores how imaging and clinical data can improve the pre-therapeutic characterization of soft tissue sarcomas. In this interview, Dr. Madelaine Hettler from University Medical Center Mannheim explains how radiology and surgery collaborate within the Network University Medicine — and why structured data are key to making therapy decisions more precise and personalized.

Rare Tumors, Big Goals: How RACOON-SAGA Aims to Improve Therapy Decisions
Related Resources
Related Resources

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy
A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™
Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…

Study Highlights the Potential of Radiomics in Medical Intervention
A recent study conducted by the Medical University of Innsbruck highlights the potential of radiomics in exploring the impacts of Radiochemotherapy…